Tomohito Sato Ryotaro Nihei Daisuke Sora Yoshiaki Nishio Masaru Takeuchi
10.3389/fimmu.2022.967972
Front Immunol
2022 Sep 29;13:967972.
bnt162b2 vaccine vogt-koyanagi-harada disease covid-19 mrna vaccines cytof heat map multiplex bead analysis uveitis
CC BY
https://pubmed.ncbi.nlm.nih.gov/36248859/
COVID-19 Panuveitis / diagnosis Panuveitis / drug therapy Panuveitis / etiology Uveomeningoencephalitic Syndrome / diagnosis Uveomeningoencephalitic Syndrome / drug therapy Uveomeningoencephalitic Syndrome / etiology
COVID-19 Panuveitis / diagnosis Panuveitis / drug therapy Panuveitis / etiology Uveomeningoencephalitic Syndrome / diagnosis Uveomeningoencephalitic Syndrome / drug therapy Uveomeningoencephalitic Syndrome / etiology Case Reports Research Support, Non-U.S. Gov't BNT162 Vaccine CD8-Positive T-Lymphocytes COVID-19 Vaccines / adverse effects Cyclosporine / therapeutic use Epitopes HLA-DR4 Antigen Humans Male Middle Aged RNA, Messenger / therapeutic use SARS-CoV-2 COVID-19 Vaccines Epitopes HLA-DR4 Antigen RNA, Messenger Cyclosporine BNT162 Vaccine
PMC9556971
36248859
Case report: Bilateral panuveitis resembling Vogt-Koyanagi-Harada disease after second dose of BNT162b2 mRNA COVID-19 vaccine
2022